文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气期间静脉阿片类药物使用与出院后阿片类药物使用的关系

Intravenous Opioid Administration During Mechanical Ventilation and Use After Hospital Discharge.
PubMed 文献 · JAMA Netw Open · 2024-06-03
一句话结论机械通气期间每日静脉阿片剂量越高,出院后1年内阿片处方和持续使用风险越高(第三分位AHR 1.25),但为回顾性关联。

这项回顾性队列研究纳入2012年1月1日至2019年12月31日美国北加州21家Kaiser Permanente医院6746例因急性呼吸衰竭接受机械通气≥24小时且存活出院的成年内科(非手术)患者,按机械通气期间中位每日静脉芬太尼等效剂量三分位分组。与未使用阿片类药物者相比,第二分位(>67至700 μg)和第三分位(>700 μg)与出院后1年内阿片处方相关(AHR分别为1.20和1.25),第三分位还与持续阿片使用相关(OR 1.44)。未观察到机械通气期间阿片剂量、既往阿片使用与出院后阿片使用之间的交互作用。作者认为需要进一步研究低阿片剂量策略的风险与获益。

要点

  • 在6746例机械通气≥24小时的内科患者中,机械通气期间中位每日芬太尼等效剂量为200 μg(IQR 40-1000 μg)。
  • 与未使用阿片类药物者相比,第三分位(>700 μg/日)与出院后1年内阿片处方相关(AHR 1.25,95%CI 1.07-1.47)。
  • 第二分位(>67至700 μg/日)也与出院后1年内阿片处方相关(AHR 1.20,95%CI 1.03-1.40),第一分位(0至67 μg/日)无统计学显著关联(AHR 1.00,95%CI 0.85-1.17)。
  • 第三分位(>700 μg/日)与出院后持续阿片使用相关(OR 1.44,95%CI 1.14-1.83)。
  • 未观察到机械通气期间阿片剂量、既往阿片使用与出院后阿片使用之间的交互作用。

适用人群与场景

  • 2012年1月1日至2019年12月31日美国北加州21家Kaiser Permanente医院收治的成年内科(非手术)患者。
  • 因急性呼吸衰竭接受机械通气≥24小时且存活出院者。

研究设计与关键结果

  • 研究类型:回顾性队列研究,纳入6746例患者,来自21家医院;中位年龄67岁(IQR 57-76岁),男性53.0%。
  • 暴露:机械通气期间中位每日静脉芬太尼等效剂量三分位:0至67 μg、>67至700 μg、>700 μg;总体中位每日芬太尼等效剂量200 μg(IQR 40-1000 μg)。
  • 主要结局:出院后1年内首次填写阿片类药物处方(n=2942例结局);与未使用阿片类药物者(n=1013)相比,第二分位AHR 1.20(95%CI 1.03-1.40),第三分位AHR 1.25(95%CI 1.07-1.47),第一分位AHR 1.00(95%CI 0.85-1.17)。
  • 次要结局:出院后持续阿片使用(n=1410例结局);第三分位 vs 未使用阿片类药物OR 1.44(95%CI 1.14-1.83)。
  • 交互作用:未观察到机械通气期间阿片剂量、既往阿片使用与出院后阿片使用之间的交互作用。
  • 基线:3114例(46.2%)在入院前一年内填写过阿片类药物处方。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性;作者在结论中提出需要进一步研究评估低阿片剂量策略的风险与获益。

对床旁实践的改变

  • 作者认为,机械通气期间阿片类药物使用与出院后阿片处方相关,需要进一步研究评估低阿片剂量策略的风险与获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Guidelines recommend an analgesia-first strategy for sedation during mechanical ventilation, but associations between opioids provided during mechanical ventilation and posthospitalization opioid-related outcomes are unclear.

OBJECTIVE: To evaluate associations between an intravenous opioid dose received during mechanical ventilation and postdischarge opioid-related outcomes in medical (nonsurgical) patients.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study evaluated adults receiving mechanical ventilation lasting 24 hours or more for acute respiratory failure and surviving hospitalization. Participants from 21 Kaiser Permanente Northern California hospitals from January 1, 2012, to December 31, 2019, were included. Data were analyzed from October 1, 2020, to October 31, 2023.

EXPOSURES: Terciles of median daily intravenous fentanyl equivalents during mechanical ventilation.

MAIN OUTCOMES AND MEASURES: The primary outcome was the first filled opioid prescription in 1 year after discharge. Secondary outcomes included persistent opioid use and opioid-associated complications. Secondary analyses tested for interaction between opioid doses during mechanical ventilation, prior opioid use, and posthospitalization opioid use. Estimates were based on multivariable-adjusted time-to-event analyses, with death as a competing risk, and censored for hospice or palliative care referral, rehospitalization with receipt of opioid, or loss of Kaiser Permanente plan membership.

RESULTS: The study included 6746 patients across 21 hospitals (median age, 67 years [IQR, 57-76 years]; 53.0% male). Of the participants, 3114 (46.2%) filled an opioid prescription in the year prior to admission. The median daily fentanyl equivalent during mechanical ventilation was 200 μg (IQR, 40-1000 μg), with terciles of 0 to 67 μg, more than 67 to 700 μg, and more than 700 μg. Compared with patients who did not receive opioids during mechanical ventilation (n = 1013), a higher daily opioid dose was associated with opioid prescriptions in the year after discharge (n = 2942 outcomes; tercile 1: adjusted hazard ratio [AHR], 1.00 [95% CI, 0.85-1.17], tercile 2: AHR, 1.20 [95% CI, 1.03-1.40], and tercile 3: AHR, 1.25 [95% CI, 1.07-1.47]). Higher doses of opioids during mechanical ventilation were also associated with persistent opioid use after hospitalization (n = 1410 outcomes; tercile 3 vs no opioids: odds ratio, 1.44 [95% CI, 1.14-1.83]). No interaction was observed between opioid dose during mechanical ventilation, prior opioid use, and posthospitalization opioid use.

CONCLUSIONS AND RELEVANCE: In this retrospective cohort study of patients receiving mechanical ventilation, opioids administered during mechanical ventilation were associated with opioid prescriptions following hospital discharge. Additional studies to evaluate risks and benefits of strategies using lower opioid doses are warranted.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Myers LC, Soltesz L, Bosch N, et al. Intravenous Opioid Administration During Mechanical Ventilation and Use After Hospital Discharge. JAMA Netw Open. 2024. PMID: 38874921. doi:10.1001/jamanetworkopen.2024.17292

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。